Explore life science companies operating throughout South East England, including biotechnology firms, CROs and research organisations.
Precision oncology drug discovery via targeted protein degradation
Dark Blue Therapeutics is a precision oncology biotech focused on discovering and developing first-in-class small molecule drugs. The company applies targeted protein degradation to exploit novel cancer vulnerabilities, with a lead programme targeting the MLLT1/3 proteins implicated in acute myeloid leukaemia. Its…
Specialist virology research services and antiviral testing
Virology Research Services is a UK-based consultancy and experimental service provider specialising in virus research. The company operates state-of-the-art containment level 2 and 3 facilities offering drug screening, antiviral product testing, and bespoke virology research services. Virology Research Services serves…
Circulating tumour cell liquid biopsy technology for cancer research and diagnostics
CelLBxHealth is a Guildford-based liquid biopsy company that develops and manufactures microfluidic circulating tumour cell harvesting technology and provides associated laboratory services. Its FDA-cleared instrument captures intact circulating tumour cells from blood samples for downstream genomic, transcriptomic,…
PCR platform enabling precision diagnostics on standard lab instruments
Signatur Biosciences is a biotechnology company developing a molecular diagnostic platform that encodes complex RNA gene expression signatures into single qPCR reactions. The technology enables precision diagnostics to be performed on standard laboratory instruments already present in clinical settings, removing…
Bioanalytical instruments and patient-derived organoid expansion services
Molecular Devices develops bioanalytical instruments, laboratory automation and cell-based research technologies for drug discovery. Its portfolio includes microplate readers, high-content imaging systems, clone screening instruments and laboratory analysis software. The company acquired Cardiff organoid specialist…
Contract development and manufacture of nanofibrous biomaterials for medical devices
The Electrospinning Company designs, develops, and manufactures nanofibrous biomaterials for implantable medical devices and regenerative medicine applications. Using electrospinning technology, the company produces four proprietary membrane platforms: resorbable Mimetix, permanent Kalyptix, biosynthetic Symatix, and…
Year-long subcutaneous drug-releasing implants for chronic disease management
imphatec is a drug delivery company developing subcutaneous implants that release medicines steadily for up to a year, with the aim of replacing daily tablets for people managing chronic and long-term conditions. Its implants are formulated to deliver a customised daily dose of a drug from a polymer matrix placed…
Enzyme-based platform for sustainable industrial chemical manufacture
HydRegen is a biotechnology company developing enzyme immobilisation platforms that replace heavy-metal catalysts in redox and hydrogenation reactions. The technology uses hydrogen gas to power NADH-dependent enzymes on carbon supports, enabling continuous flow processing of fine chemicals and active pharmaceutical…
Clinical and laboratory diagnostics systems for the UK market
Roche Diagnostics is the UK diagnostics subsidiary of F. Hoffmann-La Roche, based in Burgess Hill, West Sussex. The company supplies high-throughput laboratory analysers, reagents, and diagnostic software to NHS hospitals, clinical laboratories, and research institutions across the UK. Its portfolio spans clinical…
T cell-based tuberculosis diagnostics and clinical laboratory testing services
Oxford Immunotec is an Abingdon-based diagnostics company developing, manufacturing, and supplying T cell-based diagnostic tests for infectious and immunological diseases. Its platform measures specific T cell immune responses to inform clinical diagnosis, with the T-SPOT.TB test for tuberculosis detection cleared by…
Specialty enzyme manufacturer serving food, diagnostics and pharmaceutical industries
Amano Enzyme Europe is the UK subsidiary of Japanese specialty enzyme manufacturer Amano Enzyme Inc, serving as its EMEA hub. The company supplies microbial enzymes for food and beverage processing, dietary supplements, pharmaceutical manufacturing and clinical diagnostics. Its UK laboratories support enzyme…
UK distributor of analytical instruments and laboratory equipment
ATG Scientific Limited is a distributor of laboratory instruments and equipment for analytical chemistry, life sciences, and materials characterisation laboratories across the UK, Ireland, and Europe. The company represents a portfolio of international manufacturers, supplying surface plasmon resonance instruments,…
TCR bispecific immunotherapies for cancer and infectious disease
Immunocore is a commercial-stage biopharma developing T cell receptor bispecific immunotherapies. Its lead product tebentafusp received FDA approval in 2022 for metastatic uveal melanoma and generated $400 million in revenue in 2025. Three Phase 3 trials are enrolling across melanoma indications, with topline data…
Shaking incubators and bioreactors for cell and microbial culture
Infors UK is the UK arm of a Swiss manufacturer of incubator shakers, bioreactors and bioprocess control software. The company supplies laboratory equipment for growing bacteria, yeast, fungi and mammalian, insect and plant cells, from screening through to pilot-scale process development. It also provides…
Antibody therapies depleting pathogenic T cells for autoimmune disease cure
Re-Aim Therapeutics is a biotechnology company developing antibody-based therapies designed to achieve functional cures for T cell-mediated autoimmune diseases. The company's approach selectively depletes pathogenic T cell subsets that drive chronic inflammation, using precise targeting of disease-relevant membrane…
In vitro immunology CRO for pre-clinical drug development
Immundnz is a contract research organisation specialising in in vitro immunology services for pharmaceutical and biotechnology clients. The company designs and applies customised and standard immunological assays to assess immune safety, efficacy, and response to candidate therapeutics during pre-clinical development.…
Pre-cancer intervention to prevent cancer before it develops
Omos Biosciences is an early-stage biotechnology company developing approaches to cancer prevention through intervention at the pre-cancerous stage, rather than treatment of established disease. The company's strategy builds on established precedents in early cancer prevention, such as polyp removal to prevent…
mRNA vaccine manufacturer and R&D partner
Moderna is a company developing and manufacturing mRNA-based medicines and vaccines across infectious disease, oncology and rare disease. Its UK Innovation and Technology Centre, opened at Harwell in September 2025, is the first facility in the UK capable of onshore mRNA vaccine manufacturing, with capacity for up to…
Autophagy-enhancing small molecule drugs for neurodegeneration and rare disease
Samsara Therapeutics is a drug discovery company developing first-in-class small molecule therapeutics that restore autophagy, the cellular process of degrading and recycling damaged proteins, which declines with age and is dysfunctional in multiple diseases. Its platform identifies and chemically optimises…
Analytical instrumentation for life science, clinical and industrial research
Shimadzu UK is the British subsidiary of Shimadzu Corporation, a global manufacturer of analytical and measuring instruments. Its UK portfolio spans liquid and gas chromatography, mass spectrometry, spectroscopy, environmental monitoring, and materials testing systems serving pharmaceutical, biotechnology, clinical,…